Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anna Viola, Andrea Fontana, Alessandra Belvedere, Riccardo Scoglio, Giuseppe Costantino, Aldo Sitibondo, Marco Muscianisi, Santi Inferrera, Lucia Maria Bruno, Angela Alibrandi, Gianluca Trifirò & Walter Fries. (2020) Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach. Scandinavian Journal of Gastroenterology 55:10, pages 1176-1184.
Read now
Read now
Emidio Scarpellini, Lucrezia Laterza, Gianluca Ianiro, Jan Tack, Ludovico Abenavoli & Antonio Gasbarrini. (2016) Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 17:10, pages 1395-1402.
Read now
Read now
Pamela J Hornby. (2015) Drug discovery approaches to irritable bowel syndrome. Expert Opinion on Drug Discovery 10:8, pages 809-824.
Read now
Read now
Articles from other publishers (35)
Kosar Namakin, Meysam Hassani Moghaddam, Sara Sadeghzadeh, Maryam Mehranpour, Kimia Vakili, Mobina Fathi, Ahmadreza Golshan, Amir-Hossein Bayat, Amir-Hossein Tajik, Neda Eskandari, Ibrahim Mohammadzadeh, Soheila Zamanlui Benisi, Abbas Aliaghaei & Mohammad-Amin Abdollahifar. (2023) Elderberry diet improves gut-brain axis dysfunction, neuroinflammation, and cognitive impairment in the rat model of irritable bowel syndrome. Metabolic Brain Disease 38:5, pages 1555-1572.
Crossref
Crossref
Zhao-Chun Chi. (2022) Progress in research of low-grade inflammation in irritable bowel syndrome. World Chinese Journal of Digestology 30:24, pages 1051-1065.
Crossref
Crossref
María Jesús Rodríguez-Sojo, Jorge Garcia-Garcia, Antonio Jesús Ruiz-Malagón, Patricia Diez-Echave, Laura Hidalgo-García, José Alberto Molina-Tijeras, Elena González-Lozano, Laura López-Escanez, María Elena Rodríguez-Cabezas, Maria José Rodríguez-Sánchez, Alba Rodríguez-Nogales, Cristina Mediavilla & Julio Galvez. (2022) Beneficial Effects of Limosilactobacillus fermentum in the DCA Experimental Model of Irritable Bowel Syndrome in Rats. Nutrients 15:1, pages 24.
Crossref
Crossref
Sanghyun Kim, Bora Keum, Junhyoung Byun, Byoungjae Kim, Kijeong Lee, Jiwoo Yeon, Jaemin Lee, Hyuksoon Choi, Eunsun Kim, Yoontae Jeen, Hongsik Lee, Hoonjai Chun & Taehoon Kim. (2021) Colonic Mucosal Immune Activation in Mice with Ovalbumin-Induced Allergic Airway Disease: Association between Allergic Airway Disease and Irritable Bowel Syndrome. International Journal of Molecular Sciences 23:1, pages 181.
Crossref
Crossref
Xue Jin, Payam Gharibani, Jieyun Yin & Jiande D. Z. Chen. (2021) Neuro-Immune Modulation Effects of Sacral Nerve Stimulation for Visceral Hypersensitivity in Rats. Frontiers in Neuroscience 15.
Crossref
Crossref
Saranya Vilvanathan. 2021. Introduction to Basics of Pharmacology and Toxicology. Introduction to Basics of Pharmacology and Toxicology
613
620
.
Daniel Hoyer. (2020) Targeting the 5-HT system: Potential side effects. Neuropharmacology 179, pages 108233.
Crossref
Crossref
José Antonio Uranga, Vicente Martínez & Raquel Abalo. (2020) Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use. Molecules 25:18, pages 4314.
Crossref
Crossref
Yu Zhang, Hua Zhang, Wen Zhang, Yingjuan Zhang, Wei Wang & Lihong Nie. (2020) LncRNA XIST modulates 5-hydroxytrytophan-induced visceral hypersensitivity by epigenetic silencing of the SERT gene in mice with diarrhea-predominant IBS. Cellular Signalling 73, pages 109674.
Crossref
Crossref
Gintautas Grabauskas, Xiaoyin Wu, Jun Gao, Ji-Yao Li, Danielle Kim Turgeon & Chung Owyang. (2020) Prostaglandin E2, Produced by Mast Cells in Colon Tissues From Patients With Irritable Bowel Syndrome, Contributes to Visceral Hypersensitivity in Mice. Gastroenterology 158:8, pages 2195-2207.e6.
Crossref
Crossref
Steven L. Wright. (2020) Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review. Advances in Therapy 37:6, pages 2604-2619.
Crossref
Crossref
Jinjoo Kim, Kumsun Cho, Joo Sung Kim, Hyun Chae Jung, Bumsik Kim, Myeong Soo Park, Geun Eog Ji, Joo-Youn Cho & Kyoung Sup Hong. (2019) Probiotic treatment induced change of inflammation related metabolites in IBS-D patients/double-blind, randomized, placebo-controlled trial. Food Science and Biotechnology 29:6, pages 837-844.
Crossref
Crossref
Ana Isabel Ferreira, Mónica Garrido & Fernando Castro-Poças. (2020) Irritable Bowel Syndrome: News from an Old Disorder. GE - Portuguese Journal of Gastroenterology 27:4, pages 255-268.
Crossref
Crossref
Fen Wang, Shuxing He, Jian Yan, Lianren Mai & Liangjun Yang. (2020) Effects of herb-partitioned moxibustion for diarrhoea-predominant irritable bowel syndrome. Medicine 99:34, pages e21817.
Crossref
Crossref
I.A.M. van Thiel, S. Botschuijver, W.J. de Jonge & J. Seppen. (2020) Painful interactions: Microbial compounds and visceral pain. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:1, pages 165534.
Crossref
Crossref
Satoshi Endo, Tomoe Matsuoka, Tsubasa Nishiyama, Yuki Arai, Hirohito Kashiwagi, Naohito Abe, Masayoshi Oyama, Toshiyuki Matsunaga & Akira Ikari. (2019) Flavonol glycosides of Rosa multiflora regulates intestinal barrier function through inhibiting claudin expression in differentiated Caco-2 cells. Nutrition Research 72, pages 92-104.
Crossref
Crossref
Roxana Cojocariu, Alin Ciobica, Ioana-Miruna Balmus, Samson Guenne, Anca Trifan, Carol Stanciu, Luminita Hrițcu & Radu Lefter. (2019)
Antioxidant Capacity and Behavioral Relevance of a Polyphenolic Extract of
Chrysanthellum americanum
in a Rat Model of Irritable Bowel Syndrome
. Oxidative Medicine and Cellular Longevity 2019, pages 1-13.
Crossref
Crossref
Hans Törnblom, Richard Goosey, Gwen Wiseman, Stephen Baker & Anton Emmanuel. (2018) Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys. United European Gastroenterology Journal 6:9, pages 1417-1427.
Crossref
Crossref
Maria C. Urdaci, Marie Lefevre, Guylene Lafforgue, Christel Cartier, Bertrand Rodriguez & Jean Fioramonti. (2018) Antidiarrheal Action of Bacillus subtilis CU1 CNCM I-2745 and Lactobacillus plantarum CNCM I-4547 in Mice. Frontiers in Microbiology 9.
Crossref
Crossref
S. Fukudo, K. Matsueda, K. Haruma, M. Ida, H. Hayase, H. Akiho, Y. Nakashima & M. Hongo. (2017) Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study. Neurogastroenterology & Motility 29:6, pages e13023.
Crossref
Crossref
Jessie Pettit & Richard Glickman-Simon. (2016) Osteopathic Manipulative Therapy for Preterm Infants, Acupuncture for Menopausal Symptoms, Mindfulness-Based Stress Reduction for Chronic Low Back Pain, Chocolate for Ischemic Heart Disease, Berberine for Irritable Bowel Syndrome. EXPLORE 12:5, pages 388-392.
Crossref
Crossref
N. Cenac, M. Castro, C. Desormeaux, P. Colin, M. Sie, M. Ranger & N. Vergnolle. (2016) A novel orally administered trimebutine compound (GIC-1001) is anti-nociceptive and features peripheral opioid agonistic activity and Hydrogen Sulphide-releasing capacity in mice. European Journal of Pain 20:5, pages 723-730.
Crossref
Crossref
Lei Zhang, Jun Song & Xiaohua Hou. (2016) Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside. Journal of Neurogastroenterology and Motility 22:2, pages 181-192.
Crossref
Crossref
Chunqiu Chen, Chunhua Tao, Zhongchen Liu, Meiling Lu, Qiuhui Pan, Lijun Zheng, Qing Li, Zhenshun Song & Jakub Fichna. (2015) A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Phytotherapy Research 29:11, pages 1822-1827.
Crossref
Crossref
M. Corsetti, F. Akyuz & J. Tack. (2015) Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndrome. Neurogastroenterology & Motility 27:10, pages 1354-1370.
Crossref
Crossref
C M Keenan, M A Storr, G A Thakur, J T Wood, J Wager-Miller, A Straiker, M R Eno, S P Nikas, M Bashashati, H Hu, K Mackie, A Makriyannis & K A Sharkey. (2015) AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner. British Journal of Pharmacology 172:9, pages 2406-2418.
Crossref
Crossref
Daniel Hoyer. 2015. Antitargets and Drug Safety. Antitargets and Drug Safety
57
80
.
Tina Didari. (2015) Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology 21:10, pages 3072.
Crossref
Crossref
Tomohisa Mori, Sachiko Komiya, Jumpei Ohya, Naoki Uzawa, Koichi Sugiyama, Yusuke Saitoh, Masahiro Shibasaki & Tsutomu Suzuki. (2014) Involvement of 5-HT2 receptors in the expression of withdrawal diarrhea in morphine-dependent mice. European Journal of Pharmacology 740, pages 160-167.
Crossref
Crossref
Paolo Caraceni, Francesca Borrelli, Ferdinando A. Giannone & Angelo A. Izzo. 2014. Cannabinoids. Cannabinoids
219
260
.
Madhusudan Grover & Michael Camilleri. (2014) Ramosetron in Irritable Bowel Syndrome With Diarrhea: New Hope or the Same Old Story?. Clinical Gastroenterology and Hepatology 12:6, pages 960-962.
Crossref
Crossref
H. L. DuPont. (2014) Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Alimentary Pharmacology & Therapeutics 39:10, pages 1033-1042.
Crossref
Crossref
A. C. Ford, P. Bercik, D. G. Morgan, C. Bolino, M. I. Pintos‐Sanchez & P. Moayyedi. (2013) Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria. Alimentary Pharmacology & Therapeutics 39:3, pages 312-321.
Crossref
Crossref
A Young Seo, Nayoung Kim & Dong Hyun Oh. (2013) Abdominal Bloating: Pathophysiology and Treatment. Journal of Neurogastroenterology and Motility 19:4, pages 433-453.
Crossref
Crossref
Michael Camilleri. (2013) Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. Journal of Clinical Investigation 123:10, pages 4111-4120.
Crossref
Crossref